期刊文献+

南宁市居民血脂异常患病率调查分析 被引量:5

ANALYSIS OF THE PREVALENCE OF SERUM LIPID DISORDER IN NANNING CITIZEN,CHINA
下载PDF
导出
摘要 目的:了解南宁市居民血脂水平及血脂异常患病率。方法:采用分层整群随机抽样的方法,于2003年7月至2005年12月在广西南宁市按年龄构成比例抽取年龄≥18岁,TC、TG、LDL-C、HDL-C等资料完整的15 765例,统计人群的血脂水平及血脂异常患病率。结果:抽样人群TC、TG、HDL-C及LDL-C水平分别为(5.33±1.13)mmol/L、(1.73±1.42)mmol/L、(1.46±0.35)mmol/L、(2.93±0.82)mmol/L,校正年龄后分别为4.95,1.48,1、50,2.75mmol/L;抽样人群总血脂异常患病率为68.2%,其中男性为71.8%,女性为62.5%,标化率分别为51.5%,58.1%,43.5%。结论:南宁市居民有较高的血脂水平,血脂异常患病率高,防治血脂异常迫在眉睫。 Objective:To study the serum lipid level in Nanning City. Methods: Using stratified cluster years old and over with complete data of serum lipi s and prevalence of lipid abnormalities random sampling method, selected the d in Nanning city of Guangxi from 2003 agnostic criteria of dyslipidemia used prevention and treatment of dyslipide Results: Mean levels of TC, TG, HDL-C and LDL-C were 5.33±1.13, 1. spec and lipid men of the population residents aged 18 to 2005. Thedi- mia guidelines of China by 2007. 73±1.42, 1.46±0.35 and 2.93 82 mmol/L, respectively; and age corrected mean levels were 4. 95, 1.48, 1.50 and 2.75 mmol/L, re- tively. The prevalence of dyslipidemia in general population, males, and females were 68.2%, 71.8% 62.5% ; and the standardized rates were 51.5%, 58.1% and 43.5%, respectively. Conclusion: Both levels and the prevalence of dyslipidemia of resident in Nanning city were high. Prevention and treat- t of dyslipidemia are imminent.
出处 《广西医科大学学报》 CAS 2013年第2期310-313,共4页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.30260042)
关键词 血脂水平 血脂异常 患病率 流行病学 lipid level dyslipidemia prevalence epidemiology
  • 相关文献

参考文献10

二级参考文献176

共引文献5497

同被引文献87

  • 1张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 2赵文华,张坚,由悦,满青青,李红,王春荣,翟屹,李莹,金水高,杨晓光.中国18岁及以上人群血脂异常流行特点研究[J].中华预防医学杂志,2005,39(5):306-310. 被引量:524
  • 3潘兴寿,李天资,陆克兴,黄照河,蓝景生,袁锡华.壮族成年人不同性别年龄与血脂水平变化的关系[J].右江医学,2006,34(4):345-347. 被引量:3
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 5Alwan A. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Report [RI. Geneva: World Health Organization,2009.
  • 6Erqou S, Kaptoge S, Perry PL, et al. Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mor- tality [ J ]. JAMA, 2009,302 (4) : 412-423.
  • 7Cai L, Zhang L, Liu A, et al. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. [J]. J Atheroscler Thromb,2012,19(2): 159-168.
  • 8He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[ J ]. Circulation, 2004, 110 (4) : 405-411.
  • 9Lipsy RJ. The National Cholesterol Education Program Adult Treatment Panel III guidelines[J]. J Manag Care Pharm,2003,9( 1 Suppl):2-5.
  • 10Executive Summary of The Third Report of The National Cholesterol E- ducation Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel II- I)[J]. JAMA,2001,285( 19): 2486-2497.

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部